Clinical impact of laboratory error on therapeutic drug monitoring of once-daily tobramycin in cystic fibrosis: Case series

Once-daily dosing intravenous tobramycin is commonly used to treat cystic fibrosis pulmonary exacerbations. Clinicians often utilize historical therapeutic drug monitoring data to individualize the dose among patients who have been treated with tobramycin previously. This case series involves three...

Descripción completa

Detalles Bibliográficos
Autores principales: Prescott, William A, Mancuso, Michelle A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857365/
https://www.ncbi.nlm.nih.gov/pubmed/27489639
http://dx.doi.org/10.1177/2050313X14521158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857365/
https://www.ncbi.nlm.nih.gov/pubmed/27489639
http://dx.doi.org/10.1177/2050313X14521158

Ejemplares similares